TNFRSF11B and osteoporosis: Importantly, we also found that LP45 dose-dependently restored the changes in RANKL pathway factors RANKL and OPG, in the serum as well as bone marrow of GIO rats, suggesting that the anti-osteoporosis role of LP45 in the pathological setting of GIO may involve the RANKL/OPG pathway.